GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (NAS:PRTC) » Definitions » Repurchase of Stock

PRTC (PureTech Health) Repurchase of Stock : $-118.82 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PureTech Health Repurchase of Stock?

PureTech Health's Repurchase of Stock for the six months ended in Jun. 2024 was $-106.45 Mil.

PureTech Health's Repurchase of Stock for the trailing twelve months (TTM) ended in Jun. 2024 was $-118.82 Mil.

PureTech Health Repurchase of Stock Historical Data

The historical data trend for PureTech Health's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PureTech Health Repurchase of Stock Chart

PureTech Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Repurchase of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -26.49 -19.65

PureTech Health Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Repurchase of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.27 -22.23 -7.28 -12.37 -106.45

PureTech Health Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

Repurchase of Stock for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-118.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PureTech Health Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of PureTech Health's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

PureTech Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (NAS:PRTC) » Definitions » Repurchase of Stock
Comparable Companies
LSE:AVCT LSE:OXB LSE:BVXP LSE:FARN LSE:ERGO LSE:ARIX LSE:HVO LSE:SCLP LSE:FUM LSE:REDX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
PTCHF:USA PRTCl:UK PRTC:UK 0VQ:Germany
Address
6 Tide Street, Suite 400, Boston, MA, USA, 02210
Website
https://www.puretechhealth.com
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.